The new KV3.4 inhibitor BDS-I[1–8] as a potential pharmacological opportunity in Alzheimer’s disease therapy

Por Ilaria Piccialli, Roselia Ciccone, Anna Pannaccione
Publicado em 2020-01-01

Synthesis and Pharmacological Evaluation of a Novel Peptide Based on Anemonia sulcata BDS-I Toxin as a New KV3.4 Inhibitor Exerting a Neuroprotective Effect Against Amyloid-β Pepti...

Por Roselia Ciccone, Ilaria Piccialli, Paolo Grieco, Francesco Merlino, Lucio Annunziato, Anna Pannaccione
Publicado em 2019-07-01

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

Por Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, Stefano D’Errico, Roselia Ciccone, Vincenzo De Feo, Agnese Secondo, Anna Pannaccione
Publicado em 2022-05-01